Search

Your search keyword '"D. A. Zamanov"' showing total 3 results
Start Over Author "D. A. Zamanov"
3 results on '"D. A. Zamanov"'

1. Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry

Author

L. E. Korobchenko, S. A. Bayramova, V. E. Kharats, O. N. Kachalkova, A. Yu. Dmitriev, R. E. Batalov, D. P. Morgunov, I. A. Silin, A. A. Aleksandrovskiy, D. V. Kryzhanovskiy, A. B. Romanov, E. A. Pokushalov, D. S. Lebedev, V. A. Kuznetsov, G. V. Kolunin, D. A. Zamanov, S. Yu. Chetverikov, S. M. Yashin, S. V. Popov, E. A. Ivanitsky, A. I. Gorkov, S. E. Mamchur, V. A. Bazaev, and E. N. Mikhaylov

Subjects
atrial fibrillation, antiarrhythmic therapy, registry, catheter ablation, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Aim. Catheter ablation (CA) is an effective approach for rhythm control in atrial fibrillation (AF), however antiarrhythmic therapy (AAT) remains important. There is a lack of data about long-term AAT use after CA. This study evaluates AAT after CA for AF.Material and methods. In 2012-2016, EURObservational Research Programme of Atrial Fibrillation Ablation Long-Term (EORP AFA L-T) registry was conducted, which included 476 Russian patients (57,1% — men; mean age — 57,1±8,7 years). The follow-up after CA was 12 months (available in 81,9% of patients). The use of AAT was evaluated prior to hospitalization, during hospitalization for CA, as well as at 3, 6 and 12 months of follow-up.Results. Prior to CA, 439 (92,2%) patients received AAT During CA, 459 (96,4%) patients were treated with AAT. After CA, AAT was used by 463 (97,3%), 370 (94,8%), and 307 (78,7%) patients at 3, 6 and 12 months of follow-up, respectively. There was no arrhythmia recurrence in 187 (47,9%) subjects. Among these patients, 40 (21,4%) received class IC or III AAT. The peak of AAT use was found for class IC agents within 3 months after CA (P

Published
2020
Full Text
View/download PDF

2. CLINICAL CHRACTERISTICS OF PATIENTS AND RESULTS OF CATHETER ABLATION IN ATRIAL FIBRILLATION IN RUSSIA: SUBANALYSIS OF THE EUROPEAN REGISTRY 2012-2016

Author

E. N. Mikhailov, N. Z. Gasymova, S. А. Bayramova, V. E. Kharats, O. N. Kachalkova, A. Yu. Dmitriev, R. E. Batalov, D. P. Morgunov, I. A. Silin, A. A. Aleksandrovskiy, D. V. Kryzhanovskiy, A. B. Romanov, E. A. Pokushalov, D. S. Lebedev, V. A. Kuznetsov, G. V. Kolunin, D. A. Zamanov, S. Yu. Chetverikov, S. M. Yashin, S. V. Popov, E. A. Ivanitsky, A. I. Gorkov, S. E. Mamchur, V. A. Bazaev, and E. V. Shlyakhto

Subjects
atrial fibrillation, registry, catheter ablation, national study, results, subanalysis, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Aim. The results presented, of subanalysis of the catheter ablation (CA) registry in atrial fibrillation (AF) with the patients properties, specifics of CA and treatment results, in Russia comparing to European countries.Material and methods. During 2012 to 2015, totally 3742 patients included to the registry, of those 477 in Russia. In 467 Russian patients (males 56,5%; mean age 58,5 y. o.) CA AF was done. During one year 392 patients were followed up. Minimum requirements to follow-up: routine ECG registration and non less than one contact after 12 months passed.Results. In Russian patients there were more common obesity (46,1% and 29,2%, p

Published
2018
Full Text
View/download PDF

3. CLINICAL CHRACTERISTICS OF PATIENTS AND RESULTS OF CATHETER ABLATION IN ATRIAL FIBRILLATION IN RUSSIA: SUBANALYSIS OF THE EUROPEAN REGISTRY 2012-2016

Author

D. P. Morgunov, V. E. Kharats, E. N. Mikhailov, D. S. Lebedev, Roman Batalov, V. A. Bazaev, S. Yu. Chetverikov, A. A. Aleksandrovskiy, S. M. Yashin, E. A. Ivanitsky, V. Kuznetsov, Sergey V. Popov, S. А. Bayramova, O. N. Kachalkova, G. V. Kolunin, D. A. Zamanov, D. V. Kryzhanovskiy, Evgeny Shlyakhto, I. A. Silin, A. Yu. Dmitriev, E. A. Pokushalov, A. B. Romanov, N. Z. Gasymova, S. E. Mamchur, and A. I. Gorkov

Subjects
medicine.medical_specialty, medicine.medical_treatment, Catheter ablation, registry, 030204 cardiovascular system & hematology, Treatment results, national study, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, catheter ablation, subanalysis, medicine, Diseases of the circulatory (Cardiovascular) system, atrial fibrillation, 030212 general & internal medicine, Adverse effect, Cryoballoon ablation, Hypertension heart disease, business.industry, Atrial fibrillation, medicine.disease, Coronary heart disease, results, RC666-701, Heart failure, Cardiology, Cardiology and Cardiovascular Medicine, business, geographic locations
Abstract

Aim. The results presented, of subanalysis of the catheter ablation (CA) registry in atrial fibrillation (AF) with the patients properties, specifics of CA and treatment results, in Russia comparing to European countries.Material and methods. During 2012 to 2015, totally 3742 patients included to the registry, of those 477 in Russia. In 467 Russian patients (males 56,5%; mean age 58,5 y. o.) CA AF was done. During one year 392 patients were followed up. Minimum requirements to follow-up: routine ECG registration and non less than one contact after 12 months passed.Results. In Russian patients there were more common obesity (46,1% and 29,2%, pConclusion. In real clinical setting, high efficacy of CA AF was shown, resistant to antiarrhythmic therapy. In most of Russian patients there were cardiovascular comorbidities. There was lower rate of reported adverse events in Russian centers of interventional treatments.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results